EGRIFTA 7

Trademark usage description

pharmaceutical preparations for the treatment of lipodystrophy, obesity, wasting, growth hormone deficiency, cognitive impairment and traumatic brain Read More

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of lipodystrophy, obesity, wasting, growth hormone deficiency, cognitive impairment and traumatic brain injury.

Classification kind code

Mark Details

Serial Number

2321389

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 42 on 5^th Mar 2025	Advertised
Submitted for opposition 27 on 7^th Feb 2025	Approval Notice Sent
Submitted for opposition 26 on 7^th Feb 2025	Approved
Submitted for opposition 22 on 30^th Jan 2025	Search Recorded
Submitted for opposition 88 on 10^th Dec 2024	Security Interest Placed
Submitted for opposition 287 on 25^th Apr 2024	Pre-Assessment Letter Sent
Submitted for opposition 30 on 12^th Apr 2024	Filed
Submitted for opposition 1 on 12^th Apr 2024	Created
Submitted for opposition 31 on 12^th Apr 2024	Formalized